Avestar Capital’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$802K Sell
6,121
-28
-0.5% -$4.03K 0.05% 264
2025
Q4
$816K Sell
6,149
-72
-1% -$9.55K 0.05% 257
2025
Q3
$816K Sell
6,221
-333
-5% -$45.4K 0.05% 258
2025
Q2
$874K Sell
6,554
-792
-11% -$90.9K 0.06% 237
2025
Q1
$805K Buy
7,346
+1,091
+17% +$132K 0.07% 221
2024
Q4
$775K Buy
6,255
+325
+5% +$39.4K 0.07% 215
2024
Q3
$649K Buy
5,930
+66
+1% +$7.1K 0.07% 218
2024
Q2
$646K Buy
5,864
+3,256
+125% +$360K 0.07% 210
2024
Q1
$296K Buy
2,608
+399
+18% +$41K 0.03% 341
2023
Q4
$215K Buy
+2,209
New +$202K 0.02% 352
2019
Q3
Sell
-225
Closed -$12K 369
2019
Q2
$12K Hold
225
0.01% 477
2019
Q1
$13K Hold
225
0.01% 435
2018
Q4
$11K Sell
225
-436
-66% -$29.4K 0.01% 424
2018
Q3
$48K Sell
661
-9,579
-94% -$707K 0.03% 278
2018
Q2
$705K Buy
10,240
+2
+0% +$141 0.45% 42
2018
Q1
$697K Sell
10,238
-98
-0.9% -$6.98K 0.45% 42
2017
Q4
$717K Buy
+10,336
New +$670K 0.54% 24

Other funds holding EMR

Avestar Capital's EMR Position: Q1 2026 in Review

Avestar Capital reduced its Emerson Electric (EMR) stake by 0.46% in Q1 2026, selling an estimated $4.03K and leaving 6,121 shares worth $802K. The position accounts for 0.05% of the portfolio, ranked #264.

Avestar Capital first reported a position in EMR in Q4 2017 and has held it in 17 quarters since. The position peaked at $874K in Q2 2025. 2,193 funds tracked by Wall St. Rank hold EMR as of Q1 2026.

  • Avestar Capital held 6,121 shares of Emerson Electric worth $802K as of Q1 2026.
  • Avestar Capital sold 28 Emerson Electric shares in Q1 2026, an estimated $4.03K.
  • Emerson Electric made up 0.05% of Avestar Capital's portfolio in Q1 2026, its #264 holding.
  • Avestar Capital first reported a position in Emerson Electric in Q4 2017 and has held it in 17 quarters since.
  • Avestar Capital's Emerson Electric position peaked at $874K in Q2 2025.
  • 2,193 funds tracked by Wall St. Rank held Emerson Electric as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.